Latest Insider Transactions at Intuitive Surgical Inc (ISRG)
This section provides a real-time view of insider transactions for Intuitive Surgical Inc (ISRG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTUITIVE SURGICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTUITIVE SURGICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
11,545
-12.18%
|
$5,749,410
$498.87 P/Share
|
|
Mar 13
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
3,281
+3.75%
|
$889,151
$271.05 P/Share
|
|
Mar 12
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
SELL
Open market or private sale
|
Direct |
4,000
-25.53%
|
$2,048,000
$512.06 P/Share
|
|
Mar 12
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+20.24%
|
$772,000
$193.45 P/Share
|
|
Mar 11
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
SELL
Open market or private sale
|
Direct |
8,900
-23.15%
|
$4,307,600
$484.58 P/Share
|
|
Mar 11
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,834
+11.12%
|
$324,618
$177.99 P/Share
|
|
Mar 07
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
489
-18.95%
|
$260,637
$533.18 P/Share
|
|
Mar 06
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
492
-16.02%
|
$274,536
$558.95 P/Share
|
|
Mar 05
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
492
-13.8%
|
$272,568
$554.17 P/Share
|
|
Mar 05
2025
|
David J. Rosa President |
SELL
Open market or private sale
|
Direct |
16,509
-3.49%
|
$9,195,513
$557.52 P/Share
|
|
Mar 05
2025
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
29,250
+5.81%
|
$1,989,000
$68.23 P/Share
|
|
Mar 04
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
492
-12.13%
|
$276,996
$563.69 P/Share
|
|
Mar 03
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
492
-10.82%
|
$281,916
$573.78 P/Share
|
|
Mar 03
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,031
-89.57%
|
$1,748,887
$577.3 P/Share
|
|
Mar 03
2025
|
Fredrik Widman VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
810
-63.13%
|
$464,130
$573.78 P/Share
|
|
Feb 28
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Payment of exercise price or tax liability
|
Direct |
2,610
-19.21%
|
$1,469,430
$563.77 P/Share
|
|
Feb 28
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
BUY
Exercise of conversion of derivative security
|
Direct |
877
+10.91%
|
-
|
|
Feb 28
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,983
-25.08%
|
$1,679,429
$563.77 P/Share
|
|
Feb 28
2025
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,002
+13.6%
|
-
|
|
Feb 28
2025
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
233
-15.37%
|
$131,179
$563.77 P/Share
|
|
Feb 28
2025
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
468
+23.59%
|
-
|
|
Feb 28
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
3,553
-10.74%
|
$2,000,339
$563.77 P/Share
|
|
Feb 28
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,504
+8.11%
|
-
|
|
Feb 28
2025
|
Jamie Samath EVP & CFO & Enterprise Technol |
SELL
Open market or private sale
|
Direct |
188
-1.3%
|
$106,408
$566.94 P/Share
|
|
Feb 28
2025
|
Jamie Samath EVP & CFO & Enterprise Technol |
BUY
Exercise of conversion of derivative security
|
Direct |
940
+3.32%
|
$156,040
$166.41 P/Share
|
|
Feb 28
2025
|
Jamie Samath EVP & CFO & Enterprise Technol |
SELL
Payment of exercise price or tax liability
|
Direct |
2,238
-12.31%
|
$1,259,994
$563.77 P/Share
|
|
Feb 28
2025
|
Henry L Charlton EVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
2,020
-10.6%
|
$1,137,260
$563.77 P/Share
|
|
Feb 28
2025
|
Henry L Charlton EVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
752
+7.12%
|
-
|
|
Feb 28
2025
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,456
-19.02%
|
$4,197,728
$563.77 P/Share
|
|
Feb 28
2025
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,506
+10.83%
|
-
|
|
Feb 28
2025
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,475
-1.0%
|
$2,519,425
$563.77 P/Share
|
|
Feb 28
2025
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,504
+0.67%
|
-
|
|
Feb 28
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,358
-10.69%
|
$1,890,554
$563.77 P/Share
|
|
Feb 28
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,128
+6.52%
|
-
|
|
Feb 27
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
BUY
Grant, award, or other acquisition
|
Direct |
4,385
+41.11%
|
-
|
|
Feb 27
2025
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,012
+39.22%
|
-
|
|
Feb 27
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Grant, award, or other acquisition
|
Direct |
7,518
+32.61%
|
-
|
|
Feb 27
2025
|
Jamie Samath EVP & CFO & Enterprise Technol |
BUY
Grant, award, or other acquisition
|
Direct |
3,758
+30.29%
|
-
|
|
Feb 27
2025
|
Henry L Charlton EVP & Chief Commercial and Mkt |
BUY
Grant, award, or other acquisition
|
Direct |
3,758
+29.33%
|
-
|
|
Feb 27
2025
|
Gary S Guthart CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,530
+40.86%
|
-
|
|
Feb 27
2025
|
David J. Rosa President |
BUY
Grant, award, or other acquisition
|
Direct |
7,518
+3.27%
|
-
|
|
Feb 27
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,638
+27.25%
|
-
|
|
Feb 27
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,401
-87.18%
|
$1,394,981
$581.0 P/Share
|
|
Feb 26
2025
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,740
-0.64%
|
$1,570,020
$573.74 P/Share
|
|
Feb 26
2025
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,526
+1.26%
|
-
|
|
Feb 26
2025
|
Henry L Charlton EVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
1,343
-12.06%
|
$769,539
$573.74 P/Share
|
|
Feb 26
2025
|
Henry L Charlton EVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
2,998
+21.09%
|
-
|
|
Feb 26
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Payment of exercise price or tax liability
|
Direct |
1,229
-26.87%
|
$704,217
$573.74 P/Share
|
|
Feb 26
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
BUY
Exercise of conversion of derivative security
|
Direct |
2,477
+34.3%
|
-
|
|
Feb 26
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,622
-8.28%
|
$929,406
$573.74 P/Share
|